Contact
searchSearch
HMP Global

Opioid Use Disorder Topic Center

Featured Article

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
Danielle Sposato
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Danielle Sposato
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
Hannah Musick
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
Hannah Musick
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Jackie Fortiér; Nicole Leonard
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Jolynn Tumolo
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Virginia Garcia Pivik; Rae Ellen Bichell
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network

Newsfeed

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
Danielle Sposato
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Danielle Sposato
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
Hannah Musick
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
Hannah Musick
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Jackie Fortiér; Nicole Leonard
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Jolynn Tumolo
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Virginia Garcia Pivik; Rae Ellen Bichell
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network
News
Artificial Intelligence May Influence Whether Patients Can Get Pain Medication
09/06/2023
Andy Miller; Sam Whitehead
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis,...
09/06/2023
Pharmacy Learning Network
News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Maria Asimopoulos
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network
News
Class II Recall Issued for Chlorpromazine Tablets Due to Nitrosamine Impurity
04/10/2025
Danielle Sposato
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc.,...
04/10/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for QuVa Pharma Compounded Epidural Drug Products Due to Sterility Concerns
04/03/2025
Juliet Gallagher
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has...
04/03/2025
Pharmacy Learning Network

Interactive Features

Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Quiz
Mechanism of Action in Alzheimer Disease Medication
04/22/2025
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of...
04/22/2025
Pharmacy Learning Network
Quiz
Alzheimer Disease Progression After Injectable Treatments
03/12/2025
True or False: Anti-amyloid monoclonal antibody injectables, such as lecanemab and aducanumab, are FDA-approved disease-modifying treatments that can completely halt the progression of Alzheimer's disease.
True or False: Anti-amyloid monoclonal antibody injectables, such as lecanemab and aducanumab, are FDA-approved disease-modifying treatments that can completely halt the progression of Alzheimer's disease.
True or False: Anti-amyloid...
03/12/2025
Pharmacy Learning Network
Quiz
Targeting Amyloid Beta Plaques With Injectable Alzheimer Medications
02/12/2025
True or False: Monoclonal antibody injectables, such as Lecanemab and Aducanumab, are designed to slow the progression of Alzheimer disease by targeting amyloid beta plaques in the brain.
True or False: Monoclonal antibody injectables, such as Lecanemab and Aducanumab, are designed to slow the progression of Alzheimer disease by targeting amyloid beta plaques in the brain.
True or False: Monoclonal...
02/12/2025
Pharmacy Learning Network
Quiz
Alzheimer Disease Injectable Treatment Options
01/10/2025
Which of the following injectable medications is not an FDA-approved for the treatment of Alzheimer disease?Donepezil LecanemabDonanemab
Which of the following injectable medications is not an FDA-approved for the treatment of Alzheimer disease?Donepezil LecanemabDonanemab
Which of the following...
01/10/2025
Pharmacy Learning Network
Quiz
Rates of Amyloid Pathology in MS
11/19/2024
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS...
11/19/2024
Pharmacy Learning Network
Quiz
Comorbidity Risk of Alzheimer Disease and MS
10/22/2024
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
True or False: Among patients...
10/22/2024
Pharmacy Learning Network
Quiz
FDA Approval for Alzheimer Disease Treatments
10/21/2024
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB (Leqembi™) is the second Alzheimer drug that has affected the course of the disease successfully in phase 3, had a low side effect profile and then got full FDA approval.
True or False: Lecanemab-IRMB...
10/21/2024
Pharmacy Learning Network
Quiz
Understanding the Link Between Multiple Sclerosis and Alzheimer Disease
10/03/2024
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a typical multiple sclerosis (MS) history are more likely to accumulate amyloid plaques in the brain compared to those with atypical presentations.
True or False: Patients with a...
10/03/2024
Pharmacy Learning Network
Quiz
Differences in Alzheimer Disease Treatment Options
09/26/2024
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Which significant difference...
09/26/2024
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Terminology
09/26/2024
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in Alzheimer disease treatment?
What does ARIA-E stand for in...
09/26/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use